Marc Arbyn

20.8k total citations · 8 hit papers
168 papers, 12.9k citations indexed

About

Marc Arbyn is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Marc Arbyn has authored 168 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Epidemiology, 52 papers in Molecular Biology and 46 papers in Oncology. Recurrent topics in Marc Arbyn's work include Cervical Cancer and HPV Research (149 papers), Molecular Biology Techniques and Applications (50 papers) and Global Cancer Incidence and Screening (42 papers). Marc Arbyn is often cited by papers focused on Cervical Cancer and HPV Research (149 papers), Molecular Biology Techniques and Applications (50 papers) and Global Cancer Incidence and Screening (42 papers). Marc Arbyn collaborates with scholars based in Belgium, United Kingdom and United States. Marc Arbyn's co-authors include Victoria Nyawira Nyaga, Marc Aerts, Freddie Bray, Laia Bruni, Elisabete Weiderpass, Sílvia de Sanjosé, Mona Saraiya, Jacques Ferlay, Peter J.F. Snijders and Nicolas Wentzensen and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Marc Arbyn

160 papers receiving 12.7k citations

Hit Papers

Estimates of incidence and mortality of cervic... 2013 2026 2017 2021 2019 2014 2013 2022 2018 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
    2019 2.5k citations Marc Arbyn et al. profile →
  2. Metaprop: a Stata command to perform meta-analysis of binomial data
    2014 1.7k citations Victoria Nyawira Nyaga, Marc Arbyn et al. profile →
  3. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
    2013 1.2k citations Guglielmo Ronco, Peter J.F. Snijders et al. profile →
  4. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
    2022 773 citations Marc Arbyn, Partha Basu et al. profile →
  5. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
    2018 522 citations Marc Arbyn et al. profile →
  6. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis
    2016 317 citations Maria Kyrgiou, Antonios Athanasiou et al. profile →
  7. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women
    2018 259 citations Marc Arbyn, Nicolas Wentzensen et al. profile →
  8. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
    2023 142 citations Marc Arbyn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Arbyn Belgium 45 9.1k 3.7k 3.0k 2.3k 1.8k 168 12.9k
Marc Arbyn Belgium 57 12.0k 1.3× 4.7k 1.3× 4.5k 1.5× 2.1k 0.9× 2.1k 1.1× 165 14.9k
Mona Saraiya United States 57 12.1k 1.3× 5.9k 1.6× 4.5k 1.5× 1.5k 0.7× 1.8k 1.0× 262 19.0k
Rengaswamy Sankaranarayanan France 69 9.2k 1.0× 6.8k 1.8× 3.7k 1.2× 1.9k 0.8× 2.3k 1.2× 274 18.2k
Maria Kyrgiou United Kingdom 41 5.3k 0.6× 1.8k 0.5× 2.0k 0.7× 1.6k 0.7× 2.0k 1.1× 180 8.6k
Gary M. Clifford France 61 14.5k 1.6× 4.7k 1.3× 7.9k 2.7× 2.5k 1.1× 975 0.5× 171 19.6k
Xavier Castellsagué Spain 62 16.2k 1.8× 3.9k 1.0× 8.5k 2.9× 3.1k 1.3× 1.3k 0.7× 145 21.5k
Paolo Giorgi Rossi Italy 46 5.7k 0.6× 3.1k 0.8× 2.5k 0.9× 1.4k 0.6× 678 0.4× 453 10.9k
Allan Hildesheim United States 86 14.6k 1.6× 5.5k 1.5× 6.6k 2.2× 4.3k 1.9× 1.4k 0.7× 338 22.6k
Evangelos Paraskevaidis Greece 40 5.3k 0.6× 1.8k 0.5× 2.1k 0.7× 1.1k 0.5× 1.9k 1.0× 139 8.1k
Matti Lehtinen Finland 53 5.5k 0.6× 2.0k 0.5× 2.7k 0.9× 996 0.4× 586 0.3× 289 10.2k

Countries citing papers authored by Marc Arbyn

Since Specialization
Citations

This map shows the geographic impact of Marc Arbyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Arbyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Arbyn more than expected).

Fields of papers citing papers by Marc Arbyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Arbyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Arbyn. The network helps show where Marc Arbyn may publish in the future.

Co-authorship network of co-authors of Marc Arbyn

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Arbyn. A scholar is included among the top collaborators of Marc Arbyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Arbyn. Marc Arbyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keer, Severien Van, Ardashel Latsuzbaia, Davy Vanden Broeck, et al.. (2025). Equivalent Clinical Accuracy of Human Papillomavirus DNA Testing Using Cobas 4800 and 6800 Human Papillomavirus Systems in Paired Urine and Cervical Samples. Journal of Molecular Diagnostics. 27(5). 419–429. 1 indexed citations
2.
Wentzensen, Nicolas, et al.. (2025). Accuracy of HPV Self-Collection Compared with Clinician-Collected HPV Testing and Cytology: A Meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 34(9). 1467–1471.
3.
4.
Mwenda, Valerian, et al.. (2024). Baseline assessment of cervical cancer screening and treatment capacity in 25 counties in Kenya, 2022. Frontiers in Oncology. 14. 1371529–1371529. 4 indexed citations
5.
Prétet, Jean‐Luc, et al.. (2024). The Sansure® Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high‐risk HPV. Journal of Medical Virology. 96(10). e29961–e29961. 1 indexed citations
6.
Chung, Pui Yan Jenny, et al.. (2024). Intra‐ and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay. Journal of Medical Virology. 96(6). e29688–e29688. 2 indexed citations
7.
Nyaga, Victoria Nyawira, Joan Valls, Armando Baena, et al.. (2023). Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis. British Journal of Cancer. 130(4). 517–525. 11 indexed citations
8.
Latsuzbaia, Ardashel, Severien Van Keer, Davy Vanden Broeck, et al.. (2023). Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol. Journal of Molecular Diagnostics. 25(12). 957–966. 19 indexed citations
9.
Cocuzza, Clementina, et al.. (2023). Clinical performance of the novel full‐genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework. International Journal of Cancer. 154(3). 538–547. 4 indexed citations
10.
Latsuzbaia, Ardashel, Davy Vanden Broeck, Severien Van Keer, et al.. (2023). Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework. Journal of Molecular Diagnostics. 25(9). 702–708. 11 indexed citations
11.
Bhatia, Ramya, Jesper Bonde, Wim Quint, et al.. (2021). Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework. Journal of Clinical Pathology. 76(3). 172–176.
12.
Ritchie, David, Marc Arbyn, Partha Basu, et al.. (2021). Europe's path to eliminating cervical cancer as a public health problem. The Lancet Regional Health - Europe. 12. 100276–100276. 3 indexed citations
13.
Velentzis, Louiza S., Megan A. Smith, Sam Egger, et al.. (2021). The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes. Human Vaccines & Immunotherapeutics. 17(10). 3562–3576. 9 indexed citations
14.
Valenčak, Anja Oštrbenk, et al.. (2021). Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework. Journal of Clinical Microbiology. 59(6). 12 indexed citations
15.
Paraskevaidis, Evangelos, Antonios Athanasiou, Ilkka Kalliala, et al.. (2021). Invasive cervical cancer following treatment of pre-invasive lesions: A potential theory based on a small case series. European Journal of Obstetrics & Gynecology and Reproductive Biology. 264. 56–59. 2 indexed citations
16.
Xu, Lan, Anja Oštrbenk Valenčak, Mario Poljak, & Marc Arbyn. (2020). Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 Framework. Journal of Clinical Microbiology. 58(6). 11 indexed citations
17.
Benoy, Ina, Lan Xu, Davy Vanden Broeck, et al.. (2019). Using the VALGENT-3 framework to assess the clinical and analytical performance of the RIATOL qPCR HPV genotyping assay. Journal of Clinical Virology. 120. 57–62. 16 indexed citations
18.
Xu, Lan, Elizaveta Padalko, Anja Oštrbenk, Mario Poljak, & Marc Arbyn. (2018). Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework. International Journal of Molecular Sciences. 19(9). 2704–2704. 28 indexed citations
19.
Arbyn, Marc, Eliana Peeters, Ina Benoy, et al.. (2018). VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples. Journal of Clinical Virology. 107. 52–56. 84 indexed citations
20.
Ronco, Guglielmo, Annibale Biggeri, Massimo Confortini, et al.. (2012). [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].. PubMed. 36(3-4 Suppl 1). e1–72. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Arbyn Breakdown of academic impact, for papers by Mona Saraiya Breakdown of academic impact, for papers by Rengaswamy Sankaranarayanan Breakdown of academic impact, for papers by Maria Kyrgiou Breakdown of academic impact, for papers by Gary M. Clifford Breakdown of academic impact, for papers by Xavier Castellsagué Breakdown of academic impact, for papers by Paolo Giorgi Rossi Breakdown of academic impact, for papers by Allan Hildesheim Breakdown of academic impact, for papers by Evangelos Paraskevaidis Breakdown of academic impact, for papers by Matti Lehtinen
Rankless by CCL
2026